APA引文

Kamonrattana, R., Sathitsamitphong, L., Choeyprasert, W., Charoenkwan, P., Natesirinilkul, R., & Fanhchaksai, K. (2020). A randomized, open-labeled, prospective controlled study to assess the efficacy of frontline empirical intravenous piperacillin/tazobactam monotherapy in comparison with ceftazidime plus amikacin for febrile neutropenia in pediatric oncology patients.

Chicago Style Citation

Kamonrattana, Ruchirek, Lalita Sathitsamitphong, Worawut Choeyprasert, Pimlak Charoenkwan, Rungrote Natesirinilkul, and Kanda Fanhchaksai. A Randomized, Open-labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/tazobactam Monotherapy in Comparison With Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients. 2020.

MLA引文

Kamonrattana, Ruchirek, et al. A Randomized, Open-labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/tazobactam Monotherapy in Comparison With Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients. 2020.